EUCTR2015-003636-13-ES进行中（未招募）1 期
An open label, multicenter, extension study to evaluate the long-term safety of QGE031 240 mg s.c. given every 4 weeks for 52 weeks in Chronic Spontaneous Urticaria patients who completed study CQGE031C2201
ovartis Farmacéutica, S.A.0 个研究点目标入组 240 人开始时间: 2016年2月3日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •- Patients who complete study treatment epoch and at least visit 203 in the follow-up epoch in study QGE031C2201
- •- Present with active disease as defined by UAS7 ?12
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 220
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •- New onset of chronic urticaria other than CSU during the follow-up epoch of study CQGE031C2201.
研究者
相似试验
进行中（未招募）
1 期
A long-term safety study for QGE031 as an add-on therapy for adults with CSU who have completed study CQGE031C2201Chronic Spontaneous UrticariaMedDRA version: 20.0 Level: LLT Classification code 10009159 Term: Chronic urticaria System Organ Class: 100000004858EUCTR2015-003636-13-GBovartis Pharma Services AG240
进行中（未招募）
1 期
A long-term safety study for QGE031 as an add-on therapy for adults with CSU who have completed study CQGE031C2201EUCTR2015-003636-13-GRovartis Pharma AG240
进行中（未招募）
1 期
A long-term safety study for QGE031 as an add-on therapy for adults with CSU who have completed study CQGE031C2201Chronic Spontaneous UrticariaMedDRA version: 20.0 Level: LLT Classification code 10009159 Term: Chronic urticaria System Organ Class: 100000004858EUCTR2015-003636-13-DEovartis Pharma Services AG240
进行中（未招募）
1 期
An open-label extension study to evaluate the long-term safety and tolerability of LOU064 in subjects with CSEUCTR2019-001074-29-ESovartis Farmacéutica, S.A.229
进行中（未招募）
1 期
An open-label extension study to evaluate the long-term safety and tolerability of LOU064 in subjects with CSChronic Spontaneous UrticariaMedDRA version: 20.0Level: PTClassification code 10072757Term: Chronic spontaneous urticariaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2019-001074-29-SKovartis Pharma AG250